ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ACADIA Pharmaceuticals, Inc. 

3911 Sorrento Valley Boulevard

San Diego  California  92121   U.S.A.
Phone: 858-558-2871 Fax: 858-558-2872


SEARCH JOBS



Segment
Drug Discovery

Collaborations

Allergan  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Allergan  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Allergan  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.

Sunovion Pharmaceuticals Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.





 Company News
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Upcoming Investor Conferences 11/25/2014 10:57:29 AM
ACADIA Pharmaceuticals, Inc. (ACAD) To Present At Jefferies and Co. 2014 Global Healthcare Conference On November 20, 2014 11/13/2014 10:55:52 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Third Quarter 2014 Financial Results And Updates Timing Of NUPLAZID™ NDA Submission 11/11/2014 9:11:26 AM
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Third Quarter 2014 Financial Results On November 10, 2014 11/3/2014 10:09:01 AM
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™ 9/2/2014 7:40:24 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Trade Name NUPLAZID™ For Pimavanserin 8/28/2014 11:33:43 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Second Quarter 2014 Financial Results 8/6/2014 9:10:14 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Second Quarter 2014 Financial Results 8/5/2014 2:25:09 PM
ACADIA Pharmaceuticals, Inc. (ACAD) To Announce Second Quarter 2014 Financial Results On August 5, 2014 7/29/2014 9:10:34 AM
ACADIA Pharmaceuticals, Inc. (ACAD)Announces Appointment Of Stephen Davis As Executive Vice President, Chief Financial Officer And Chief Business Officer 7/15/2014 9:30:26 AM
12345678910...